LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding
Links shared publicly online about this topic.
- 961total visits
LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding
View full resource at medicalnewstoday.com
Tags: Anemia, Bleeding, Menstruation, Women's Health
Most Recently Shared on August 9, 2010 at 12:19 pm By:
LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding http://mnt.to/3H6K #womenshealth
Also Shared By:
Lysteda for the Management of Heavy Menstrual Bleeding | DrPullen.com – Medical and Health Blog
drpullen.com — “Lysteda for the Management of Heavy Menstrual Bleeding | DrPullen.com – Medical and Health Blog” View full resource at drpullen.com
Most Recently Shared on July 29, 2011 at 1:45 pm By:
Lysteda for the Management of Heavy Menstrual Bleeding | DrPullen.com – Medical and Health Blog http://fb.me/Ucuo3ECv
Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB
news-medical.net — “Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.” View full resource at news-medical.net
Most Recently Shared on October 7, 2010 at 9:25 am By:
Stroke News: Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB: Ferring... http://twurl.nl/vvakzl
Lysteda available for heavy menstrual bleeding - MPR
empr.com — “Ferring Pharmaceuticals has launched Lysteda (tranexamic acid tablets) for the treatment of cyclic heavy menstrual bleeding (HMB) in women.” View full resource at empr.com
Most Recently Shared on June 21, 2010 at 2:37 pm By:
MPR News: Lysteda available for heavy menstrual bleeding: Ferring Pharmaceuticals has launched Lysteda (tranexamic... http://bit.ly/9tlIex
Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA
news-medical.net — “Ferring Pharmaceuticals today announced an agreement that will expand its Women's Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical's LYSTEDA" (tranexamic acid), a first-in-class, non-hormonal therapy indicated specifically for treatment of women with cyclic heavy menstrual bleeding (HMB).” View full resource at news-medical.net
Most Recently Shared on May 10, 2010 at 3:00 pm By:
Stroke News: Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA: Ferring Pharmaceuticals toda... http://twurl.nl/ozmlnd
FDA approves Lysteda for treating menorrhagia
news-medical.net — “Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.” View full resource at news-medical.net
Most Recently Shared on November 16, 2009 at 5:24 pm By:
Stroke News: FDA approves Lysteda for treating menorrhagia: Xanodyne Pharmaceuticals, Inc., an inte.. http://twurl.nl/njohb3
Lysteda approved for heavy menstrual bleeding - MPR
empr.com — “The FDA has approved Lysteda (tranexamic acid tablets, from Xanodyne), a non-hormonal treatment for women suffering from menorrhaghia, cyclic heavy menstrual bleeding (HMB).” View full resource at empr.com
Most Recently Shared on November 16, 2009 at 4:27 pm By:
MPR News: Lysteda approved for heavy menstrual bleeding: The FDA has approved Lysteda (tranexamic acid tablets, fro... http://bit.ly/3Mf1Lm
Advertisement



Women's Health Line
@WomensHealth_HL
LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding http://sns.ly/CJC48 #womenshealth
1 year ago...